首页 > 市场调查报告书 > 製药

疼痛

市场调查报告书

商品编码

1567156

慢性疼痛市场：按药物类别、按适应症、按应用、按分销管道、按地区

Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs, Anticonvulsants, Antidepressants, and Others), By Indication, By Application, By Distribution Channel, By Geography

出版日期: 2024年08月27日 | 出版商:

Coherent Market Insights | 英文 260 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球慢性疼痛市场规模将达721亿美元，预计2031年将达到1,155.1亿美元，2024年至2031年复合年增长率为7%。

报告范围		报告详情
基准年	2023年	2024年市场规模	721亿美元
实际资料	2019-2023	预测期	2024年至2031年
预测 2024-2031 年复合年增长率：	7.00%	2031年价值预测	1155.1亿美元

图：2024 年按地区分類的慢性疼痛市场占有率(%)

慢性疼痛被定义为持续超过 3 个月或超过正常癒合期的疼痛。有许多疾病会导致慢性疼痛，包括关节炎、下背痛、癌症、神经系统疾病和纤维肌痛。久坐的生活方式和慢性疾病的增加可能会增加全球慢性疼痛的盛行率。慢性疼痛会限制活动能力和日常功能，对生活品质产生负面影响。全球慢性疼痛市场包括疼痛管理药物、神经调节装置和其他可缓解和改善患者预后的治疗方式。容易受到这种情况影响的老龄化人口的快速增长、医疗保健支出的增加、新产品的推出以及对管理选择的认识的提高正在推动市场的增长。

市场动态：

慢性疾病和伤害的日益流行在很大程度上导致了全球慢性疼痛发病率的上升。这包括肌肉骨骼疾病，例如骨关节炎和下背痛。老年人口的增加（更容易患此类疾病）将推动市场成长。此外，不断增长的医疗保健支出、新产品创新以及支付昂贵治疗方案的能力也将推动市场成长。然而，学名药等替代品的存在、用药违规以及某些治疗方法的副作用可能会给市场参与者带来挑战。此外，新产品核可的监管障碍也可能阻碍市场成长。新兴国家为产业参与者提供了庞大的商机。疼痛治疗方法的技术进步可能为市场成长开闢新的途径。

本研究的主要特点

该报告对全球慢性疼痛市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。

它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。

根据公司亮点、产品系列、主要亮点、业绩和策略等参数对全球慢性疼痛市场的主要企业进行了分析。

研究涵盖的主要企业包括辉瑞、礼来、GlaxoSmithKline Plc、诺华、强生、Astra Zeneca、普渡製药、远藤製药、梯瓦製药工业有限公司和 Mallinckrodt 製药。

该报告的见解使负责人和公司经营团队能够就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球慢性疼痛市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

透过用于分析全球慢性疼痛市场的各种策略矩阵，将有助于相关人员做出决策。

Pfizer Inc.
Johnson & Johnson
GlaxoSmithKline PLC
Bayer AG
Novartis AG
Endo Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Reckitt Benckiser Group plc
Medtronic plc
AstraZeneca PLC
Becton, Dickinson and Company
AbbVie Inc.
Horizon Therapeutics
Mallinckrodt Pharmaceuticals
Zynerba Pharmaceuticals
Neurocrine Biosciences
Sorrento Therapeutics
Cypress Pharmaceutical

第10章分析师建议

第十一章参考文献与调查方法

参考
调查方法
关于出版商

简介目录

Product Code: CMI4767

Global chronic pain market is estimated to be valued at USD 72.10 Bn in 2024 and is expected to reach USD 115.51 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 7% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 72.10 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2024 to 2031 CAGR:	7.00%	2031 Value Projection:	US$ 115.51 Bn

Figure. Chronic Pain Market Share (%), By Region, 2024

Chronic pain is defined as any pain lasting for more than three months or past the normal time of healing. The conditions that cause chronic pain are numerous and wide-ranging from arthritis, back pain, cancer, neurological disorders and fibromyalgia among others. Sedentary lifestyles and rising chronic diseases can increase the prevalence of chronic pain globally. It negatively impacts quality of life by limiting mobility and daily functioning. Global chronic pain market consists of drugs for pain management, neuromodulation devices, and other treatment modalities that provide relief and improve patient outcomes. Rapid growth in geriatric population who are more prone to such conditions, rise in healthcare expenditure, new product launches, and increasing awareness about management options can drive the market growth.

Market Dynamics:

Increasing prevalence of chronic diseases and injuries has significantly contributed to rising incidence of chronic pain worldwide. These include musculoskeletal disorders like osteoarthritis and lower back pain. Growing geriatric population who are more susceptible to such conditions can drive the market growth. Furthermore, greater healthcare spending, new product innovations, and ability to pay for expensive treatment options can also drive the market growth. However, presence of alternatives like generic drugs, non-compliance to medications, and side effects of certain therapies can pose challenges to market players. Moreover, regulatory hurdles for new product approvals can also hamper the market growth. Emerging economies provide major opportunities for industry players. Technological advancements in pain treatment modalities can open new avenues for the market growth.

Key features of the study:

This report provides in-depth analysis of the global chronic pain market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global chronic pain market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Eli Lilly, GlaxoSmithKline, Novartis, Johnson & Johnson, AstraZeneca, Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals Industries Ltd., and Mallinckrodt Pharmaceuticals

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global chronic pain market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic pain market

Detailed Segmentation-

By Drug Class Insights (Revenue, USD Bn, 2019 - 2031)
- Opioids
- Non-steroidal anti-inflammatory drugs (NSAIDS)
- Anticonvulsants
- Antidepressants
- Others
By Indication Insights (Revenue, USD Bn, 2019 - 2031)
- Neuropathic pain
- Arthritis pain
- Chronic back pain
- Cancer pain
- Migraine
- Fibromyalgia
- Others
By Application Insights (Revenue, USD Bn, 2019 - 2031)
- Musculoskeletal
- Neuropathy
- Oncology
- Others
By Distribution Channel Insights (Revenue, USD Bn, 2019 - 2031)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Regional Insights (Revenue, USD Bn, 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Johnson & Johnson
- GlaxoSmithKline PLC
- Bayer AG
- Novartis AG
- Endo Pharmaceuticals
- Bristol-Myers Squibb
- Eli Lilly and Company
- Teva Pharmaceutical Industries Ltd.
- Reckitt Benckiser Group plc
- Medtronic plc
- AstraZeneca PLC
- Becton, Dickinson and Company
- AbbVie Inc.
- Horizon Therapeutics
- Mallinckrodt Pharmaceuticals
- Zynerba Pharmaceuticals
- Neurocrine Biosciences
- Sorrento Therapeutics
- Cypress Pharmaceutical

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Chronic Pain Market, By Drug Class
- Global Chronic Pain Market, By Indication
- Global Chronic Pain Market, By Application
- Global Chronic Pain Market, By Distribution Channel
- Global Chronic Pain Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Chronic Pain Market, By Drug Class, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Opioids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Non-steroidal anti-inflammatory drugs (NSAIDS)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Anticonvulsants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Antidepressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

5. Global Chronic Pain Market, By Indication, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Neuropathic pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Arthritis pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Chronic back pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Cancer pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Migraine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Fibromyalgia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Chronic Pain Market, By Application, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Musculoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Neuropathy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Chronic Pain Market, By Distribution Channel, 2019-2031, (USD Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Chronic Pain Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2031, (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Drug Class, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Johnson & Johnson
GlaxoSmithKline PLC
Bayer AG
Novartis AG
Endo Pharmaceuticals
Bristol-Myers Squibb
Eli Lilly and Company
Teva Pharmaceutical Industries Ltd.
Reckitt Benckiser Group plc
Medtronic plc
AstraZeneca PLC
Becton, Dickinson and Company
AbbVie Inc.
Horizon Therapeutics
Mallinckrodt Pharmaceuticals
Zynerba Pharmaceuticals
Neurocrine Biosciences
Sorrento Therapeutics
Cypress Pharmaceutical

10. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

慢性疼痛市场：按药物类别、按适应症、按应用、按分销管道、按地区